Leslie Citrome

MedicinePsychology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Impact-Tardive Dyskinesia (Impact-TD) Scale”.

Impact-Tardive Dyskinesia (Impact-TD) Scale

The Journal of Clinical Psychiatry(2022)10.4088/jcp.22cs14563

N/A

0DataRank · unranked

9 citations

Matthew Brams, Noelle E. Carlozzi, Leslie Citrome, Nora E. Fritz, A. Robelo Hoberg +4 more

Preferences for attributes of oral antipsychotic treatments: results from a discrete-choice experiment in respondents with schizophrenia or bipolar I disorder

BMC Psychiatry(2024)10.1186/s12888-024-06034-1

N/A

0DataRank · unranked

1 citations

Marco Boeri, Caroline Vass, Cooper Bussberg, H. Panchmatia, Leslie Citrome +2 more

Antidepressant medications have evolved in terms of speed of onset of efficacy: How can we best measure antidepressant treatment response?

Current Medical Research and Opinion(2024)10.1080/03007995.2024.2323638

N/A

0DataRank · unranked

0 citations

Mark Opler, Leslie Citrome, Jan Sedway

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I

Journal of Clinical Psychopharmacology(2025)10.1097/jcp.0000000000001987

N/A

0DataRank · unranked

28 citations

Ross J. Baldessarini, Richard Balon, John Bilbily, Stanley N. Caroff, Leslie Citrome +35 more

Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II

Journal of Clinical Psychopharmacology(2025)10.1097/jcp.0000000000001990

N/A

0DataRank · unranked

28 citations

Ross J. Baldessarini, Richard Balon, John Bilbily, Stanley N. Caroff, Leslie Citrome +35 more